Kliogest

Norethisterone Acetate, Estradiol, the active ingredient in Kliogest, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and helps regulate menstrual cycles in women of reproductive age. It works by suppressing ovulation and altering cervical mucus, providing reliable birth control while also offering cycle‑stabilizing benefits.

GNH USA supplies Kliogest as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across diverse markets.

Kliogest, a combined estrogen‑progestogen oral contraceptive, is used in hormonal birth control. - Prevention of pregnancy: provides reliable contraception for women of reproductive age. - Regulation of menstrual cycles: helps achieve more predictable bleeding patterns. - Management of menstrual disorders: can be used to treat conditions such as dysmenorrhea or irregular bleeding.

Kliogest may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Nausea: mild stomach upset. - Headache: transient cranial pain. - Breast tenderness: discomfort or swelling. Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in veins. - Pulmonary embolism: clot traveling to lungs. - Severe allergic reaction: rash, swelling, difficulty breathing.

Before prescribing Kliogest, healthcare providers should consider several precautionary measures. - Assess thrombotic risk: avoid use in women with history of clotting disorders. - Screen for cardiovascular disease: contraindicated in uncontrolled hypertension or heart disease. - Evaluate liver function: caution in hepatic impairment. - Consider smoking status: avoid in women over 35 who smoke. - Pregnancy and lactation: contraindicated during pregnancy and not recommended while breastfeeding. - Store at ambient temperature: keep tablets in original packaging, protect from moisture and heat.

Kliogest can interact with other medicines, affecting its efficacy or safety. Major Interactions (Avoid): - Enzyme‑inducing antiepileptics: may reduce contraceptive effectiveness. - Anticoagulants (warfarin): increased risk of thrombosis. - Selective serotonin reuptake inhibitors (SSRIs): may increase risk of bleeding. Moderate Interactions (Monitor Closely): - Rifampin and similar antibiotics: may lower hormone levels. - St. John’s wort herbal supplements: may decrease contraceptive efficacy. - Antifungal agents (e.g., ketoconazole): may increase hormone concentrations.